Skip to main content
Providing practical opinion to support best practice for busy healthcare professionals
Login
Register
Search Site
Search
Search
Home
About
About Us
Testimonials
Journals
Aims & Scope and Instructions for Authors
European Oncology & Haematology
Oncology & Hematology Review (US)
Editorial Board
Articles
Media Gallery
Media Partners
Press Releases
FDA Approves Nivolumab/Ipilimumab Combination for Intermediate or Poor-Risk Advanced RCC
ESMO Immuno-Oncology Congress 2018: Abstracts
FDA Finalises Guidances to Accelerate the Development of Reliable, Beneficial NGS-Based Tests
EMA to Review Risk of Dosing Errors with Methotrexate
ELCC 2018 News: New Data Support First-Line Osimertinib in Patients with NSCLC and Sensitising EGFR Mutation
ELCC 2018 News: Low Baseline Endoglin Levels May Signal Improved Survival with Nintedanib in Malignant Pleural Mesothelioma
Anders Waage
Professor, Department of Hematology, University Hospital Trondheim
Prof. Waage is the author of 40+ peer review publications in international journals. His key research and clinical interests are focused on multiple myeloma.